4/24
08:38 am
cai
Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference [TheStreet.com]
Low
Report
Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference [TheStreet.com]
4/24
08:30 am
cai
Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference
Low
Report
Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference
4/20
06:03 pm
cai
Jefferies Initiates Coverage of Caris Life Sciences Inc. (CAI) With a Buy Rating [Yahoo! Finance]
Medium
Report
Jefferies Initiates Coverage of Caris Life Sciences Inc. (CAI) With a Buy Rating [Yahoo! Finance]
4/20
08:41 am
cai
Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026 [TheStreet.com]
Low
Report
Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026 [TheStreet.com]
4/20
08:30 am
cai
Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026
Medium
Report
Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026
4/17
08:45 am
cai
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center [TheStreet.com]
Low
Report
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center [TheStreet.com]
4/17
08:30 am
cai
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center
Medium
Report
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center
4/15
08:50 am
cai
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients [TheStreet.com]
Medium
Report
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients [TheStreet.com]
4/15
08:30 am
cai
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
Low
Report
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
4/13
08:34 am
cai
Caris Life Sciences (CAI) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $28.00 price target on the stock.
Medium
Report
Caris Life Sciences (CAI) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $28.00 price target on the stock.
4/10
08:00 am
cai
Caris Life Sciences (CAI) is now covered by Piper Sandler. They set a "neutral" rating and a $21.00 price target on the stock.
Medium
Report
Caris Life Sciences (CAI) is now covered by Piper Sandler. They set a "neutral" rating and a $21.00 price target on the stock.
4/8
08:13 pm
cai
Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients [Yahoo! Finance]
Medium
Report
Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients [Yahoo! Finance]
4/8
08:52 am
cai
Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients [TheStreet.com]
Low
Report
Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients [TheStreet.com]
4/8
08:30 am
cai
Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients
Low
Report
Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients
4/2
08:53 am
cai
Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies [Yahoo! Finance]
Low
Report
Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies [Yahoo! Finance]
4/2
08:35 am
cai
Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies [TheStreet.com]
Low
Report
Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies [TheStreet.com]
4/2
08:30 am
cai
Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies
Low
Report
Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies
4/1
08:41 am
cai
Caris Life Sciences (CAI) is now covered by The Goldman Sachs Group, Inc.. They set a "buy" rating and a $27.00 price target on the stock.
Medium
Report
Caris Life Sciences (CAI) is now covered by The Goldman Sachs Group, Inc.. They set a "buy" rating and a $27.00 price target on the stock.
3/31
06:14 pm
cai
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect [Yahoo! Finance]
Medium
Report
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect [Yahoo! Finance]
3/31
06:11 pm
cai
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect [TheStreet.com]
Medium
Report
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect [TheStreet.com]
3/31
06:00 pm
cai
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect
Medium
Report
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect
3/26
08:49 am
cai
Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung Cancer [Yahoo! Finance]
Low
Report
Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung Cancer [Yahoo! Finance]
3/26
08:30 am
cai
Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung Cancer
Low
Report
Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung Cancer
3/25
08:30 am
cai
Caris Life Sciences to Present Six Oncology Studies Utilizing Proprietary Multimodal Data at the AACR Annual Meeting 2026
Medium
Report
Caris Life Sciences to Present Six Oncology Studies Utilizing Proprietary Multimodal Data at the AACR Annual Meeting 2026
3/24
09:09 am
cai
Caris Life Sciences Highlights the Importance of DPYD Testing in Colorectal Cancer During Colorectal Cancer Awareness Month [TheStreet.com]
Medium
Report
Caris Life Sciences Highlights the Importance of DPYD Testing in Colorectal Cancer During Colorectal Cancer Awareness Month [TheStreet.com]